Facetten
Zugriff
Einrichtung
Medientyp
- Text 4
Karte
Erscheinungsjahr
Autor/in
- Richardson, Paul G
- Weisel, Katja 3
- Facon, Thierry 2
- Oriol, Albert 2
- Schjesvold, Fredrik 2
- alle zeigen
Sprache
- Englisch 4
4 Einträge gefunden
-
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
- Dimopoulos, Meletios A
- Richardson, Paul G
- Bahlis, Nizar J
- Grosicki, Sebastian
- Cavo, Michele
- Beksaç, Meral
- Legieć, Wojciech
-
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
- Lonial, Sagar
- Popat, Rakesh
- Hulin, Cyrille
- Jagannath, Sundar
- Oriol, Albert
- Richardson, Paul G
- Facon, Thierry
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: a subanalysis of OPTIMISMM by clinical characteristics
- Richardson, Paul G
- Schjesvold, Fredrik
- Weisel, Katja
- Moreau, Philippe
- Anderson, Larry D
- White, Darrell
- Rodriguez-Otero, Paula
-
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
- Richardson, Paul G
- Oriol, Albert
- Beksac, Meral
- Liberati, Anna Marina
- Galli, Monica
- Schjesvold, Fredrik
- Lindsay, Jindriska